Department profile
Dechert LLP

Pharma/Life Sciences: Competition

France Guide 2026 : France

Share profile

Dechert LLP

Rankings

About

Provided by Dechert LLP

Dechert’s life sciences team in France represents companies ranging from multinational giants to emerging companies involving all aspects of the life sciences industry, including pharmaceuticals, biotechnology, drug discovery, genomics, biopharmaceuticals, diagnostics, medical devices and healthcare. We also assist with investment funds in life sciences investments.

With life sciences lawyers in the U.S., Europe, Asia and the Middle East, we are well-positioned to handle the most complex cross-border matters for our clients. Our representation of both large pharmaceutical companies as well as smaller and mid-size biotechnology and specialty pharmaceutical companies is a distinguishing feature of our firm, and our Paris office allows us to structure and negotiate transactions from the perspective of both parties.

Our extensive experience includes:

  • M&A and private equity transactions
  • Reorganizations and international tax planning
  • Antitrust/competition
  • Pharmaceutical contractual and regulatory advice
  • Corporate law
  • Licensing and corporate partnering
  • Strategic IP counseling/complex IP litigation
  • Litigation and international arbitration
  • Corporate finance and capital markets

Chambers Review

Provided by Chambers

Pharma/Life Sciences: Competition - France

What the Team is Known For

Dechert is a top firm that regularly handles corporate and competition matters in the sector, advising on M&A transactions and related merger filing and control aspects. The team is also experienced in providing regulatory advice on the pricing of medical devices and medicines, with further expertise in abuse of dominant position cases. The law firm offers assistance with cross-border matters, notably across Europe, the USA and Asia.

À propos de l’équipe

Dechert est un cabinet de premier plan qui traite régulièrement des questions de droit des sociétés et de concurrence dans le secteur, en conseillant sur les opérations de M&A et les aspects connexes du dépôt et du contrôle des concentrations. L’équipe a également de l’expérience dans le conseils réglementaires sur la tarification des dispositifs médicaux et des médicaments, avec une expertise supplémentaire dans les cas d’abus de position dominante. Le cabinet d’avocats offre une assistance dans le cadre de dossiers transfrontaliers, notamment en Europe, aux États-Unis et en Asie.

View ranking table

Work Highlights

Provided by Chambers

  • Dechert advised ARCHIMED on its acquisition of a majority stake in FIM Medical.

  • Dechert a conseillé ARCHIMED lors de son acquisition d'une participation majoritaire dans FIM Medical.

Strengths

Provided by Chambers

  • The firm has a good grasp of the regulatory constraints of our business.

    Pharma/Life Sciences: Competition respondentFrance

  • The department has cutting-edge expertise.

    Pharma/Life Sciences: Competition respondentFrance

  • Each team member demonstrates a high level of competence and commitment, providing us with confidence in the process.

    Pharma/Life Sciences: Competition respondentFrance

  • Ce département a une expertise de pointe.

    Pharma/Life Sciences: Competition respondentFrance

  • Le cbainet comprend bien les contraintes réglementaires de notre secteur d'activité.

    Pharma/Life Sciences: Competition respondentFrance

  • Chaque membre de l'équipe fait preuve d'un haut niveau de compétence et d'engagement, ce qui nous permet d'avoir confiance dans le processus.

    Pharma/Life Sciences: Competition respondentFrance

Notable Practitioners

Provided by Chambers

  • Mélanie Thill-Tayara
    Mélanie Thill-Tayara

    Mélanie Thill-Tayara

    Mélanie Thill-Tayara is a leading practitioner with significant expertise in abuse of dominant position and merger control cases. She represents multinational pharmaceutical companies before French and European competition authorities.

    Mélanie Thill-Tayara est une avocate de premier plan dotée d’une expertise significative dans les affaires d’abus de position dominante et de contrôle des concentrations. Elle représente des multinationales pharmaceutiques devant les autorités de concurrence françaises et européennes.

    • I had a very good experience working with Mélanie Thill-Tayara.

      Pharma/Life Sciences: Competition respondentFrance

    • J'ai eu une très bonne expérience de travail avec Mélanie Thill-Tayara.

      Pharma/Life Sciences: Competition respondentFrance
    View profile
  • Sophie Pelé
    Sophie Pelé

    Sophie Pelé

    Sophie Pelé is noted for her expertise in regulatory issues and assists with both domestic and cross-border mandates.

    Sophie Pelé est reconnue pour son expertise en matière réglementaire et intervient dans le cadre de mandats nationaux et transfrontaliers.

    • I am impressed by her ability to understand customer needs, be accessible to non-legal persons and provide pragmatic legal advice.

      Pharma/Life Sciences: Competition respondentFrance

    • Sophie has a very good knowledge of the health ecosystem. She analyses the subjects we submit to her with rigor.

      Pharma/Life Sciences: Competition respondentFrance

    • Je suis impressionné par sa capacité à comprendre les besoins des clients, à être accessible aux personnes non juristes et à fournir des conseils juridiques pragmatiques.

      Pharma/Life Sciences: Competition respondentFrance

    • Sophie a une très bonne connaissance de l'écosystème de la santé. Elle analyse avec rigueur les sujets que nous lui soumettons.

      Pharma/Life Sciences: Competition respondentFrance
    View profile

Ranked Individuals at Dechert LLP (2)

France

Members

Provided by Dechert LLP

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership